Adenoid Vegetations in Adult Patients

The Clinical Characteristics of Adenoid Vegetations in Adult Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06041074

Enrollment

161

Registered

2023-09-18

Start date

2023-09-15

Completion date

2023-12-31

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid Vegetation

Brief summary

In this observational cross-sectional study the clinical characteristics of adenoid vegetations in adulthood will be investigated.

Detailed description

Adenoid vegetations typically appear in childhood and are well described in this population. However, in adulthood, adenoid vegetations appear rarely and their characteristics have not been described. The clinical characteristics of adenoid vegetations in adulthood will be investigated, and compared with clinical characteristics of adenoid vegetations in childhood.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 105 Years

Healthy volunteers

Inclusion criteria

* patient with adenoid vegetations

Exclusion criteria

* other concomitant otorhinolaryngological diagnoses * hypertrophy of the tonsils * oropharyngeal carcinomas * chronic sinuitis * allergic rhinitis

Design outcomes

Primary

Measure	Time frame	Description
Symptoms	2 months	The leading symptom (patient's main complaint, the reason for seeing the doctor) will we recorded for each participant

Secondary

Measure	Time frame	Description
OTS (otoscopic)	2 months	The otoscopic findings will be recorded in both groups
RNS (rhinoscopic)	2 months	The rhinoscopic findings will be recorded in both groups
OFS (oropharyngoscopic)	2 months	The oropharyngoscopic findings will be recorded in both groups
PRNS (post-rhynoscopic)	2 months	The post-rhynoscopic findings will be recorded in both groups
Duration of symptoms	2 months	The duration of leading symptom (in months) will be recorded for each participant
PHD ( pathohistological findings)	2 months	The pathohistological findings will be recorded in both groups
Surgery	2 months	The type of surgery will be recorded in both groups
Outcome	2 months	The outcome (the relief of the leading symptom) will be recorded in both groups
Recurrence	2 months	The recurrence will be recorded in both groups
Referring physician	2 months	The physician (primary or secondary level) who referred the patient to ENT (Ear Nose and Throat doctor) will be recorded in both groups

Countries

Croatia

Outcome results